These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 23708219)
1. Sarpogrelate dilates cerebral arteries in the absence of exogenous serotonin. Kawamura M; Ishiguro M; Nagamine T; Houkin K Neurol Med Chir (Tokyo); 2013; 53(5):291-8. PubMed ID: 23708219 [TBL] [Abstract][Full Text] [Related]
2. Effects of M-1, a Major Metabolite of Sarpogrelate, on 5-HT-Induced Constriction of Isolated Human Internal Thoracic Artery. Tanaka-Totoribe N; Hidaka M; Gamoh S; Yokota A; Nakamura E; Kuwabara M; Tsunezumi J; Yamamoto R Biol Pharm Bull; 2020 Dec; 43(12):1979-1982. PubMed ID: 32999137 [TBL] [Abstract][Full Text] [Related]
3. Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts. Kodama A; Komori K; Kajikuri J; Itoh T J Vasc Surg; 2009 Sep; 50(3):617-25. PubMed ID: 19700096 [TBL] [Abstract][Full Text] [Related]
4. Effects of sarpogrelate, a novel 5-HT2 antagonist, on 5-HT-induced endothelium-dependent relaxations in porcine coronary artery. Rashid M; Nakazawa M; Nagatomo T Jpn J Pharmacol; 2002 Aug; 89(4):405-12. PubMed ID: 12233819 [TBL] [Abstract][Full Text] [Related]
5. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice. Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591 [TBL] [Abstract][Full Text] [Related]